Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Orelabrutinib in Patients with Indolent Non-Hodgkin Lymphoma (iNHL) Who Are Intolerant to Prior Bruton Tyrosine Kinase Inhibitors (BTKi): Updated Results from a Phase 2 Study

Lin Shen, Jing Bao, Lihong Shou, Ying Lu, Qi Zhu, Li Wang, Weili Zhao

Blood (2024) 144 (Supplement 1): 4399.

https://doi.org/10.1182/blood-2024-204547

Published: 2024

Journal Articles

Optimal Timing and Impact of Allogeneic Peripheral Blood Stem Cell Transplantation in Adult T-Cell Lymphoblastic Lymphoma: Insights from a Large Cohort Multi-Center Real-World Study in Shanghai

Fangfang Yu, Jiahua Niu, Jianmin Yang, Jian Hou, Siguo Hao, Aibin Liang, Hong Xiong, Qi Zhu, Ligen Liu, Jun Shi, Juan Du, Bobin Chen, Rong Wei, Wenli Zhao, Lihua Sun, Yunhua Hou, Rong Tao, Xianmin Song

Blood (2024) 144 (Supplement 1): 7818.

https://doi.org/10.1182/blood-2024-199964

Published: 2024

Journal Articles

The Efficacy and Safety of Cladribine in Combination with Cytarabine ,ATRA, G-CSF and Mitoxantrone(Claag-M Regimen)in Relapsed/Refractory AML : A Phase 1/2, Prospective, Single-Arm, Multicenter Study

Tinghua Zhang, Yinghua Xie, Limin Zhao, Xiyao Han, Yingting Lu, Jing Zhang, Yanhui Xie, Qi Zhu, Lihua Sun, Li Yang, Ligen Liu

Blood (2019) 134 (Supplement_1): 3843.

https://doi.org/10.1182/blood-2019-125739

Published: 2019

Journal Articles

The Outcome of Refractory or Relapsed but Not Refractory Diffuse Large B-Cell Lymphoma in China: Results from the Real-TREND Study

Shuo Wang, Li Wang, CC Chang, Jianda Hu, Xi Zhang, Qi Zhu, Guohui Cui, Wenbin Qian, Bobin Chen, Weili Zhao

Blood (2018) 132 (Supplement 1): 5913.

https://doi.org/10.1182/blood-2018-99-118623

Published: 2018

Journal Articles

Synergic effects of arsenic trioxide and cAMP during acute promyelocytic leukemia cell maturation subtends a novel signaling cross-talk

Qi Zhu, Ji-Wang Zhang, Hai-Qing Zhu, Yu-Lei Shen, Maria Flexor, Pei-Ming Jia, Yun Yu, Xun Cai, Samuel Waxman, Michel Lanotte, Sai-Juan Chen, Zhu Chen, Jian-Hua Tong

Blood (2002) 99 (3): 1014–1022.

https://doi.org/10.1182/blood.V99.3.1014

Published: 2002

NARROW

Orelabrutinib in Patients with Indolent Non-Hodgkin Lymphoma (iNHL) Who Are Intolerant to Prior Bruton Tyrosine Kinase Inhibitors (BTKi): Updated Results from a Phase 2 Study

Optimal Timing and Impact of Allogeneic Peripheral Blood Stem Cell Transplantation in Adult T-Cell Lymphoblastic Lymphoma: Insights from a Large Cohort Multi-Center Real-World Study in Shanghai

The Efficacy and Safety of Cladribine in Combination with Cytarabine ,ATRA, G-CSF and Mitoxantrone(Claag-M Regimen)in Relapsed/Refractory AML : A Phase 1/2, Prospective, Single-Arm, Multicenter Study

The Outcome of Refractory or Relapsed but Not Refractory Diffuse Large B-Cell Lymphoma in China: Results from the Real-TREND Study

Synergic effects of arsenic trioxide and cAMP during acute promyelocytic leukemia cell maturation subtends a novel signaling cross-talk

Email alerts

ASH Publications

American Society of Hematology

Orelabrutinib in Patients with Indolent Non-Hodgkin Lymphoma (iNHL) Who Are Intolerant to Prior Bruton Tyrosine Kinase Inhibitors (BTKi): Updated Results from a Phase 2 Study

Optimal Timing and Impact of Allogeneic Peripheral Blood Stem Cell Transplantation in Adult T-Cell Lymphoblastic Lymphoma: Insights from a Large Cohort Multi-Center Real-World Study in Shanghai

The Efficacy and Safety of Cladribine in Combination with Cytarabine ,ATRA, G-CSF and Mitoxantrone(Claag-M Regimen)in Relapsed/Refractory AML : A Phase 1/2, Prospective, Single-Arm, Multicenter Study

The Outcome of Refractory or Relapsed but Not Refractory Diffuse Large B-Cell Lymphoma in China: Results from the Real-TREND Study

Synergic effects of arsenic trioxide and cAMP during acute promyelocytic leukemia cell maturation subtends a novel signaling cross-talk

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only